Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | BMP1 | P13497 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7840106 | 0.81 | RECQL (0.38) | RECQLMAPTPOLBGAAKMT2A | |
| SCHEMBL9843190 | 0.80 | RECQL (0.38) | RECQLMAPTPOLBGAAKMT2A | |
| SCHEMBL8801770 | 0.79 | L3MBTL1 (0.39) | RECQLMAPTPOLBGAAKMT2A | |
| SCHEMBL8198330 | 0.78 | MAPT (0.38) | RECQLMAPTPOLBGAAKMT2A | |
| SCHEMBL8805455 | 0.77 | RECQL (0.38) | RECQLMAPTPOLBGAAKMT2A | |
| SCHEMBL7036880 | 0.75 | CHRNB2 (0.42) | MAPTPOLBGAAKMT2AALDH1A1 | |
| SCHEMBL4655363 | 0.74 | RECQL (0.44) | RECQLMAPTPOLBGAAKMT2A | |
| SCHEMBL4655361 | 0.74 | RECQL (0.44) | RECQLMAPTPOLBGAAKMT2A | |
| SCHEMBL12077058 | 0.73 | KMT2A (0.43) | RECQLMAPTPOLBGAAKMT2A | |
| Clothianidine SCHEMBL21215 | 0.71 | RECQL (0.39) | RECQLMAPTPOLBGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0873325-B1 | PROCESS FOR PRODUCING GUANIDINE DERIVATIVES, INTERMEDIATES THEREFOR AND THEIR PRODUCTION | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-03-12 | — | — | EP | claimed |
| US-6166215-A | Process for producing guanidine derivatives, intermediates therefor and their production | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-26 | — | — | US | claimed |
| US-6008363-A | REACTING AN O-METHYL-N-NITROSOUREA COMPOUND OR SALT WITH AN HETEROCYCLIC AMINE COMPOUND; FREE OF BAD SMELL; HIGH YIELD | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-12-28 | — | — | US | claimed |
| EP-0873325-A1 | PROCESS FOR PRODUCING GUANIDINE DERIVATIVES, INTERMEDIATES THEREFOR AND THEIR PRODUCTION | Takeda Chemical Industries, Ltd. (JP) | 1998-10-28 | — | — | EP | claimed |
| WO-1997000867-A1 | PROCESS FOR PRODUCING GUANIDINE DERIVATIVES, INTERMEDIATES THEREFOR AND THEIR PRODUCTION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-01-09 | — | — | WO | claimed |
| US-8754235-B2 | Method for producing 5-(aminomethyl)-2-chlorothiazole | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-06-17 | — | — | US | disclosed |
| EP-2511270-A1 | METHOD FOR PRODUCING 5-(AMINOMETHYL)-2-CHLOROTHIAZOLE | Sumitomo Chemical Company, Limited (JP) | 2012-10-17 | — | — | EP | disclosed |
| US-20120226049-A1 | METHOD FOR PRODUCING 5-(AMINOMETHYL)-2-CHLOROTHIAZOLE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-09-06 | — | — | US | disclosed |
| EP-1997802-A1 | METHOD FOR NITRATING ISOUREA | Sumitomo Chemical Company, Limited (JP) | 2008-12-03 | — | — | EP | disclosed |
| EP-0873325-B1 | PROCESS FOR PRODUCING GUANIDINE DERIVATIVES, INTERMEDIATES THEREFOR AND THEIR PRODUCTION | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2003-03-12 | — | — | EP | disclosed |
| EP-1042292-B1 | METHOD FOR PRODUCING ISOUREAS | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2002-11-06 | — | — | EP | disclosed |
| US-6265582-B1 | NITRATING O-SUBSTITUTED ISOUREA, REACTING WITH AMINOMETHYL-SUBSTITUTED HETEROCYCLIC COMPOUND | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| US-6166215-A | Process for producing guanidine derivatives, intermediates therefor and their production | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-26 | — | — | US | disclosed |
| JP-2000281665-A | METHOD FOR PURIFYING GUANIDINE DERIVATIVE | TAKEDA CHEM IND LTD | 2000-10-10 | — | — | JP | disclosed |
| US-6008363-A | REACTING AN O-METHYL-N-NITROSOUREA COMPOUND OR SALT WITH AN HETEROCYCLIC AMINE COMPOUND; FREE OF BAD SMELL; HIGH YIELD | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-12-28 | — | — | US | disclosed |
| EP-0873325-A1 | PROCESS FOR PRODUCING GUANIDINE DERIVATIVES, INTERMEDIATES THEREFOR AND THEIR PRODUCTION | Takeda Chemical Industries, Ltd. (JP) | 1998-10-28 | — | — | EP | disclosed |
| WO-1997000867-A1 | PROCESS FOR PRODUCING GUANIDINE DERIVATIVES, INTERMEDIATES THEREFOR AND THEIR PRODUCTION | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-01-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120226049-A1 | METHOD FOR PRODUCING 5-(AMINOMETHYL)-2-CHLOROTHIAZOLE | NOS2, CA2, AASDHPPT | RECQL 4598/4885MAPT 1162/4885POLB 2729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.